Related Posts
Every year, more than a million lives are lost to hepatitis. The TherVacB team of clinical researchers, hepatologists and virologists is not waiting for change – we’re working hard to make it happen!
A better understanding of the hepatitis B infection and the HBV-mediated disease improves therapies – with your support as HBV patient!
As patient living with chronic hepatitis B in Italy, Spain, UK and Germany, you can join the European HBV Patient Registry anytime at one of TherVacB’s study centers. By joining, TherVacB clinicians will perform your routine visits. Additionally, the physicians will collect your patient data on virological and immunological parameters in a systematic way. Since its launch, the collection of patient data has been growing continuously. This collection helps clinicians to identify patients for the upcoming TherVacB vaccination trial and other studies on HBV treatment and cure. With your support, researchers can better understand the natural course of a hepatitis B infection, develop or refine therapies and help you and the HBV community worldwide.
Are you interested? Have a look at the map of participating clinical sites in Europe. Read on about the purpose of the European Patient Registry. And reach out to us, if you are interested in taking part!
Stay in touch with the Community – Join the Community Forum on 25 July to mark World Hepatitis Day 2023 !
On 25th July, 2 PM CEST / 1 PM BST, the World Hepatitis Alliance hosts the FREE and fully virtual WHD Community Forum. Join in for insights into the experiences, perspectives and unmet needs of people diagnosed with and living with hepatitis across the world. The panelists will explore global conversations around eliminating hepatitis by 2030 and why we are not waiting for hepatitis elimination. People living with hepatitis are welcome to share experiences and offer possible solutions to address challenges faced, as a result of the disease.
Do you want to join? Register anytime by clicking this link!
